The case was detected last week in Marshall County, a North Mississippi CWD management zone.
Nasal autoantibodies likely latch on to viral molecules, preventing excessive inflammation.
A modeling study estimates the MenACWY vaccine prevented 500 cases of invasive meningococcal disease in US adolescents from 2005 to 2021.
After spiking during the COVID-19 pandemic, rates of HAIs in US acute-care hospitals fell in 2023.
The virus was identified in 2% of 988 participants with tick bites.
As a steady polio rise continues in Pakistan, the country has now reported 45 cases this year.
Washington, for example, has reported nearly 1,200 cases this year, up sharply from 2023.
Meanwhile, COVID activity remained low amid a shift in variant proportions and RSV levels rose in 3 US regions.
The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.
The cases include two deer in Conway and Stone counties in Arkansas and an elk in Montana's Hunting District 704.
Meanwhile, Uganda’s outbreak is rapidly expanding, mostly involving intimate close-contact spread and among sexual networks.
The 42-day countdown period covers two virus incubation periods.
The intervention at 10 critical-access hospitals was associated with a small but potentially clinically significant reduction in ASB treatment.
The patients are from 4 different provinces, and all but one is a child.
The adverse event in the earlier clinical trial involved amyotrophic lateral sclerosis, which wasn't related to vaccination.
People reporting long-COVID symptoms had elevated levels of cytokines, which are proteins the body makes to fight inflammation.
The algorithm was roughly 3% more accurate than the relevant diagnostic code and less biased toward certain populations, the authors say.
Hawaii is the only US state that hasn't reported H5N1 avian flu in birds or animals.
A genomic surveillance study identified several multidrug-resistant, high-risk clones of E Coli and Klebsiella pneumoniae in Kenya, Uganda, and Jordan.
A total of 438 confirmed and probable cases of meningococcal disease were reported in 2023, the most US cases since 2013.
The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.
A total of 104 people have been sickened, with 34 hospitalizations, 4 cases of hemolytic uremic syndrome, and 1 death.
In other developments, Alveo Technologies announced an agreement with the CDC to develop a rapid multiplex test for point-of-need use.
The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.
UK health officials say the increase is largely due to an uptick in antibiotic-resistant Escherichia coli infections.
